AI-Guided STAR Method Achieves First Successful Pregnancy in Azoospermia Case

Reviewed byNidhi Govil

2 Sources

Share

Columbia University researchers report the first successful pregnancy using their AI-powered STAR method to recover sperm from men with azoospermia. The breakthrough technology helped a couple conceive after nearly 20 years of trying.

News article

Revolutionary AI Technology Transforms Male Infertility Treatment

Researchers at Columbia University Fertility Center have achieved a groundbreaking milestone in reproductive medicine, reporting the first successful pregnancy using an artificial intelligence-guided method to recover sperm in men with azoospermia. The achievement, published in The Lancet, represents a significant advancement for couples facing male-factor infertility, which accounts for approximately 40% of all infertility cases

1

.

Azoospermia, a condition affecting 10-15% of men with infertility, presents a particularly challenging scenario where ejaculate contains little or no sperm. "A semen sample can appear totally normal, but when you look under the microscope you discover just a sea of cellular debris, with no sperm visible," explains Dr. Zev Williams, senior author of the study and Director of the Columbia University Fertility Center

2

.

Traditional Methods Fall Short

Current treatment options for men with azoospermia have proven inadequate and often problematic. Surgical sperm extraction from the testes frequently fails and can cause complications including vascular problems, inflammation, and temporary testosterone level decreases. Alternative approaches involving specialized laboratories employ technicians to manually inspect semen samplesβ€”a process that is both lengthy and expensive, often requiring samples to be processed with centrifuges or other agents that can damage the very sperm cells they're trying to recover

1

.

"The field has really been challenged to find a better way to identify and retrieve viable sperm cells in men with exceedingly low sperm counts," Williams notes, highlighting the urgent need for innovative solutions

2

.

The STAR Method: A Technological Marvel

The breakthrough came through the development of STAR (Sperm Tracking and Recovery), a sophisticated method that combines multiple cutting-edge technologies. Led by Dr. Hemant Suryawanshi, an assistant professor of reproductive sciences at Columbia University Vagelos College of Physicians and Surgeons, the interdisciplinary team brought together experts in advanced imaging techniques, microfluidics, and reproductive endocrinology

1

.

The STAR system operates through a remarkable three-step process. First, high-powered imaging technology scans semen samples from men with azoospermia, capturing over 8 million images in under an hour. Artificial intelligence algorithms then analyze these images to identify viable sperm cells within the sample. Finally, a microfluidic chip equipped with tiny, hair-like channels isolates the portion of the semen sample containing the identified sperm cell, while a robot gently removes the sperm within milliseconds for immediate use in embryo creation or cryopreservation

2

.

First Clinical Success After Two Decades

The technology's first clinical application involved a patient who had been attempting to start a family for nearly 20 years. This individual had undergone multiple IVF cycles at various centers, several manual sperm searches, and two surgical procedures to extract spermβ€”all unsuccessful. When STAR was applied to a 3.5 mL semen sample from this patient, the system scanned 2.5 million images over approximately two hours, successfully identifying two viable sperm cells. These cells were subsequently used to create two embryos, resulting in a successful pregnancy

1

.

"You only need one healthy sperm to create an embryo," Williams emphasizes, underscoring the potential impact of finding even minimal viable genetic material

2

.

Future Implications and Ongoing Research

While the findings are based on a single case study, they demonstrate the feasibility of this technology to overcome long-standing barriers in treating male infertility. The success story provides hope for countless couples who have been told they have little chance of having a biological child due to male-factor infertility. Larger clinical studies are currently underway to evaluate the efficacy of STAR across broader patient populations, which will be crucial for establishing the method's reliability and potential for widespread clinical adoption

1

.

TheOutpost.ai

Your Daily Dose of Curated AI News

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Spend less time searching for the latest in AI and get straight to action.

Β© 2025 Triveous Technologies Private Limited
Instagram logo
LinkedIn logo